Clinical Trial Update: Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating pralatrexate and gemcitabine with B12 and folic acid in relapsed/refractory lymphoproliferative malignancies, including Hodg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Hodgkin Lymphoma
• Or Refractory Lymphoproliferative Malignancies
• Peripheral T-cell Lymphoma
• Waldenstrom Macroglobulinemia

Drugs mentioned

• B12 (cobalamin)
• Gemcitabine (Gemcitabine)
• Pralatrexate (pralatrexate)
• folic acid (folic acid)

Snippet

Sponsor: Acrotech Biopharma Inc. | Conditions: Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-09-18